Search Results

You are looking at 151 - 160 of 947 items for :

  • "NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines" x
  • Refine by Access: All x
Clear All
Full access

Andrew D. Zelenetz

During his presentation at the NCCN 19th Annual Conference, Dr. Andrew D. Zelenetz reviewed the updates to the 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin’s Lymphomas. Dr. Zelenetz first discussed the updates for diffuse large B-cell lymphoma (DLBCL), focusing primarily on the emergence of MYC-positive DLBCL; the limited role of imaging in early-stage disease; new treatment options; the challenge of tumor heterogeneity; and the impact of cell of origin in the selection of future therapies. Then, on behalf of Dr. Steven Horwitz, Dr. Zelenetz presented the new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.

Full access

George Handzo, Jill M. Bowden, and Stephen King

Spiritual care and chaplaincy have been part of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Distress Management since the first meeting of the panel in 1997, possibly the first time this degree of spiritual care and chaplaincy care integration occurred in cancer care. Since that time, the chaplaincy care section of the guidelines, especially chaplain assessment categories derived from a spiritual care assessment, have provided a major resource for healthcare chaplaincy and have served as a model for integrating chaplaincy into the overall team practice of healthcare. However, this section of the NCCN Guidelines has not been substantially updated since it was originally written. During those 20 years, the practice of healthcare chaplaincy and the research that supports it have grown substantially. In the last year, at the request of the panel, we have updated the chaplaincy care section to fully integrate recently published evidence in spiritual care in healthcare, adding more value to this important set of guidelines. Those updates appear in the 2019 version of the NCCN Guidelines. This article discusses the history of chaplaincy involvement in the NCCN Guidelines for Distress Management and the precedent it set for the integration of chaplaincy in other efforts that followed. Integration of this section of the Guidelines into the spiritual care practice at Memorial Sloan Kettering Cancer Center is presented as an example of how these guidelines can be put into practice to improve patient care. Finally, a summary of the recent research by Drs. Kenneth Pargament and Julie Exline is presented as the foundation for the revised chaplain assessment categories and interventions.

Full access

In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Multiple Myeloma that appeared in the October issue of JNCCN ( JNCCN 2011;9:1146-1183), an error appears in the Lenalidomide as Maintenance Therapy After Autologous SCT

Full access

In the November 2019 issue, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gestational Trophoblastic Neoplasia, Version 2.2019 (J Natl Compr Canc Netw 2019, doi: 10.6004/jnccn.2019.0053 ) contained an error. In 2 places

Full access

In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Kidney Cancer that appeared in the September issue of JNCCN ( JNCCN 2011;9: 960-977 ), an error appears in the Targeted Therapy section on page 970. The second sentence

Full access

. Hinkel; Kristie A. Minogue; and Diane E. Paul, MS, RN, National Comprehensive Cancer Network. Updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) and NCCN Drugs & Biologics Compendium (NCCN Compendium™) for Prostate Cancer The

Full access

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Melanoma: Cutaneous, published in this issue (page 439), include the latest updates. To assist readers interested in noting how the guidelines were updated, highlights of

Full access

Numune Teaching Hospital, Turkey Call for Correspondence JNCCN is committed to providing a forum to enhance collaboration between academic medicine and the community physician. We welcome comments about the NCCN Clinical Practice Guidelines in

Full access

Patient Guides for Cancer mobile app. Free NCCN Pocket Guidelines Available for Myeloproliferative Neoplasms NCCN is pleased to offer a pocket-sized version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for

Full access

to reflect the most recent updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Esophageal Cancer. The 2015 version addresses appropriate referral to cancer genetics professionals, and new recommendations for surveillance